$GNBT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENEREX BIOTECHNOLOGY CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENEREX BIOTECHNOLOGY CORP. Get notifications about new insider transactions in GENEREX BIOTECHNOLOGY CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 2.12 | 945 | 2,003 | 945 | 0 to 945 | |
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 2.10 | 555 | 1,166 | 555 | 0 to 555 | |
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 1.05 | 8,000 | 8,400 | 8,000 | 0 to 8 K | |
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 1.03 | 300 | 309 | 300 | 0 to 300 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Ro Andrew | SVP & Chief Investm ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Purcell Richard David Jr. | SVP of Research & D ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Lyman Gary Herbert | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP General Counsel ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Corrao Mark | CFO & Treasurer | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Centofanti Kevin | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Anderson James H Jr. | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 0 | |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Buy | M | 0.00 | 1,667,671 | 1,668 | 5,615,070 | 3.9 M to 5.6 M (+42.25 %) |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 0 | |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 4,447,111 | 4,447 | 15,821,836 | 11.4 M to 15.8 M (+39.10 %) |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 1,667,671 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Von Hofe Eric | President of Subsid ... | Option Exercise | M | 0.00 | 7,610,911 | 7,611 | 7,610,911 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 1,667,671 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 845,492 | 845 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 595,239 | 595 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,928,925 | 1,929 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 546,448 | 546 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Buy | M | 0.00 | 5,583,775 | 5,584 | 3,916,104 | -1,667,671 to 3.9 M (-334.82 %) |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 4,447,111 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 1,587,300 | 1,587 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 5,143,787 | 5,144 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 1,457,195 | 1,457 | 0 | |
Feb 12 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 14,890,033 | 14,890 | 10,442,992 | -4,447,041 to 10.4 M (-334.83 %) |
Apr 27 2015 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | M | 0.00 | 1,810,345 | 1,810 | 0 | |
Apr 27 2015 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | M | 0.00 | 592,593 | 593 | 0 | |
Apr 27 2015 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | M | 0.00 | 2,553,191 | 2,553 | 0 | |
Apr 27 2015 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | M | 0.00 | 918,033 | 918 | 0 | |
Apr 27 2015 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Buy | M | 0.00 | 5,874,162 | 5,874 | 5,874,162 | 0 to 5.9 M |
Oct 08 2014 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 470,726 | 471 | 0 | |
Oct 08 2014 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Buy | M | 0.00 | 470,726 | 471 | 470,726 | 0 to 470.7 K |
Oct 08 2014 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | M | 0.00 | 35,714 | 36 | 0 | |
Oct 08 2014 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Buy | M | 0.00 | 35,714 | 36 | 35,714 | 0 to 35.7 K |
Oct 08 2014 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | M | 0.00 | 35,714 | 36 | 0 | |
Oct 08 2014 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Buy | M | 0.00 | 35,714 | 36 | 35,714 | 0 to 35.7 K |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | Von Hofe Eric | Director | Option Exercise | A | 0.00 | 988,029 | 988 | 988,029 | |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.00 | 890,804 | 891 | 890,804 | |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President and CEO | Option Exercise | A | 0.00 | 2,254,640 | 2,255 | 2,254,640 | |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 845,492 | 845 | 845,492 | |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | A | 0.00 | 845,492 | 845 | 845,492 | |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.00 | 1,810,345 | 1,810 | 1,810,345 | |
Nov 01 2013 | GNBT | GENEREX BIOTECHNOL ... | Anderson James H Jr. | Director | Option Exercise | A | 0.00 | 718,391 | 718 | 718,391 | |
Jun 20 2013 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Sell | S | 0.04 | 2,524,164 | 89,608 | 0 | 2.5 M to 0 (-100.00 %) |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.00 | 592,593 | 593 | 592,593 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | Von Hofe Eric | Director | Option Exercise | A | 0.00 | 682,210 | 682 | 682,210 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 2,524,164 | 2,524 | 0 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Buy | M | 0.00 | 2,524,164 | 2,524 | 2,524,164 | 0 to 2.5 M |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | A | 0.00 | 595,239 | 595 | 595,239 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.00 | 328,042 | 328 | 328,042 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | Anderson James H Jr. | Director | Option Exercise | A | 0.00 | 1,296,296 | 1,296 | 1,296,296 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | A | 0.00 | 1,587,300 | 1,587 | 1,587,300 | |
Jun 10 2013 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 595,239 | 595 | 595,239 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.00 | 5,143,787 | 5,144 | 5,143,787 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | CHIEF OPERATING OFF ... | Option Exercise | A | 0.00 | 1,928,925 | 1,929 | 1,928,925 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | CHIEF FINANCIAL OFF ... | Option Exercise | A | 0.00 | 1,928,925 | 1,929 | 1,928,925 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | Von Hofe Eric | Director | Option Exercise | A | 0.00 | 2,177,267 | 2,177 | 2,177,267 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | Anderson James H Jr. | Director | Option Exercise | A | 0.00 | 1,139,818 | 1,140 | 1,139,818 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.00 | 2,553,191 | 2,553 | 2,553,191 | |
Apr 01 2013 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.00 | 1,413,374 | 1,413 | 1,413,374 | |
Jul 05 2012 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Option Exercise | M | 0.00 | 508,197 | 508 | 0 | |
Jul 05 2012 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Buy | M | 0.00 | 508,197 | 508 | 508,197 | 0 to 508.2 K |
Jun 27 2012 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Acting Chief Financ ... | Sell | S | 0.09 | 546,448 | 50,383 | 0 | 546.4 K to 0 (-100.00 %) |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.00 | 918,033 | 918 | 918,033 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Acting Chief Financ ... | Option Exercise | M | 0.00 | 546,448 | 546 | 0 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Acting Chief Financ ... | Buy | M | 0.00 | 546,448 | 546 | 546,448 | 0 to 546.4 K |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | Anderson James H Jr. | Director | Option Exercise | A | 0.00 | 409,836 | 410 | 409,836 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | A | 0.00 | 546,448 | 546 | 546,448 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | FELLOWS STEPHEN | Acting Chief Financ ... | Option Exercise | A | 0.00 | 546,448 | 546 | 546,448 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | Von Hofe Eric | Director | Option Exercise | A | 0.00 | 626,292 | 626 | 626,292 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President,CEO,Gener ... | Option Exercise | A | 0.00 | 1,457,195 | 1,457 | 1,457,195 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.00 | 508,197 | 508 | 508,197 | |
Jun 21 2012 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Option Exercise | A | 0.00 | 508,197 | 508 | 508,197 | |
May 11 2011 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | Director | Sell | S | 0.23 | 15,000 | 3,450 | 975,478 | 990.5 K to 975.5 K (-1.51 %) |
May 09 2011 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | Director | Sell | S | 0.23 | 20,000 | 4,500 | 990,478 | 1 M to 990.5 K (-1.98 %) |
May 04 2011 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | Director | Sell | S | 0.22 | 25,000 | 5,500 | 1,010,478 | 1 M to 1 M (-2.41 %) |
Apr 25 2011 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.28 | 200,000 | 56,400 | 200,000 | |
Apr 25 2011 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Option Exercise | A | 0.28 | 200,000 | 56,400 | 200,000 | |
Apr 25 2011 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | See Remarks | Option Exercise | A | 0.28 | 1,500,000 | 423,000 | 1,500,000 | |
Apr 25 2011 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.28 | 500,000 | 141,000 | 500,000 | |
Apr 07 2011 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | See Remarks | Buy | P | 0.24 | 20,000 | 4,780 | 286,077 | 266.1 K to 286.1 K (+7.52 %) |
Jan 03 2011 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO& Treas. | Option Exercise | M | 0.00 | 576,752 | 577 | 0 | |
Jan 03 2011 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO& Treas. | Buy | M | 0.00 | 576,752 | 577 | 1,035,478 | 458.7 K to 1 M (+125.73 %) |
Oct 27 2010 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO& Treas. | Buy | P | 0.35 | 54,000 | 18,900 | 458,726 | 404.7 K to 458.7 K (+13.34 %) |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | CEO & President | Option Exercise | A | 0.64 | 500,000 | 320,000 | 500,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | CEO & President | Option Exercise | A | 0.00 | 1,120,704 | 1,121 | 1,120,704 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | CEO & President | Option Exercise | D | 0.00 | 1,120,704 | 1,121 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | CEO & President | Option Exercise | A | 0.61 | 250,000 | 152,500 | 250,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | CEO & President | Option Exercise | D | 0.61 | 250,000 | 152,500 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Option Exercise | A | 0.64 | 300,000 | 192,000 | 300,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Option Exercise | A | 0.00 | 470,276 | 470 | 470,726 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Option Exercise | D | 0.00 | 470,726 | 471 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Option Exercise | A | 0.61 | 250,000 | 152,500 | 250,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Option Exercise | D | 0.61 | 250,000 | 152,500 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BERNSTEIN GERALD | VP, Medical Affairs | Option Exercise | A | 0.61 | 100,000 | 61,000 | 100,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BERNSTEIN GERALD | VP, Medical Affairs | Option Exercise | D | 0.61 | 100,000 | 61,000 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.56 | 100,000 | 56,000 | 100,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | D | 0.56 | 100,000 | 56,000 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.00 | 35,714 | 36 | 35,714 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | D | 0.00 | 35,714 | 36 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 0.94 | 70,000 | 65,800 | 70,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | D | 0.94 | 70,000 | 65,800 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.64 | 100,000 | 64,000 | 100,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.56 | 100,000 | 56,000 | 100,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | D | 0.56 | 100,000 | 56,000 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.00 | 35,714 | 36 | 35,714 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | D | 0.00 | 35,714 | 36 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | A | 0.94 | 70,000 | 65,800 | 70,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | D | 0.94 | 70,000 | 65,800 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Option Exercise | A | 0.64 | 400,000 | 256,000 | 400,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Option Exercise | A | 0.00 | 576,572 | 577 | 576,752 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Option Exercise | D | 0.00 | 576,572 | 577 | 0 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Option Exercise | A | 0.61 | 250,000 | 152,500 | 250,000 | |
Mar 10 2010 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Option Exercise | D | 0.61 | 250,000 | 152,500 | 0 | |
Jan 04 2010 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Buy | P | 0.52 | 8,700 | 4,524 | 266,077 | 257.4 K to 266.1 K (+3.38 %) |
Nov 16 2009 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Buy | P | 0.51 | 10,000 | 5,100 | 404,726 | 394.7 K to 404.7 K (+2.53 %) |
Nov 16 2009 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | CEO & Pres. | Buy | P | 0.51 | 10,000 | 5,100 | 226,127 | 216.1 K to 226.1 K (+4.63 %) |
Nov 16 2009 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Buy | P | 0.49 | 10,000 | 4,900 | 257,377 | 247.4 K to 257.4 K (+4.04 %) |
Nov 16 2009 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Buy | P | 0.49 | 10,000 | 4,900 | 60,000 | 50 K to 60 K (+20.00 %) |
Nov 13 2009 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Sell | S | 0.50 | 50,000 | 25,000 | 50,000 | 100 K to 50 K (-50.00 %) |
Oct 19 2009 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Sell | S | 0.69 | 2,700 | 1,863 | 100,000 | 102.7 K to 100 K (-2.63 %) |
Jan 12 2009 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Buy | P | 0.33 | 2,200 | 726 | 247,377 | 245.2 K to 247.4 K (+0.90 %) |
Jan 12 2009 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Buy | P | 0.32 | 10,159 | 3,251 | 245,177 | 235 K to 245.2 K (+4.32 %) |
Nov 03 2008 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Buy | P | 0.38 | 24,500 | 9,310 | 235,018 | 210.5 K to 235 K (+11.64 %) |
Nov 03 2008 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP & General Couns ... | Buy | P | 0.37 | 500 | 185 | 210,518 | 210 K to 210.5 K (+0.24 %) |
Oct 14 2008 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Buy | P | 0.31 | 3,800 | 1,178 | 394,726 | 390.9 K to 394.7 K (+0.97 %) |
Oct 14 2008 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Buy | P | 0.30 | 11,200 | 3,360 | 390,926 | 379.7 K to 390.9 K (+2.95 %) |
May 29 2008 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Treas. & ... | Option Exercise | A | 0.96 | 125,000 | 120,000 | 125,000 | |
May 29 2008 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | President & CEO | Option Exercise | A | 0.96 | 50,000 | 48,000 | 50,000 | |
Apr 21 2008 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | VP & General Counse ... | Option Exercise | M | 0.89 | 250,000 | 222,500 | 0 | |
Apr 21 2008 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | VP & General Counse ... | Sell | S | 1.16 | 128,342 | 148,877 | 210,018 | 338.4 K to 210 K (-37.93 %) |
Apr 21 2008 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | VP & General Counse ... | Sell | S | 1.14 | 100,000 | 114,000 | 338,360 | 438.4 K to 338.4 K (-22.81 %) |
Apr 21 2008 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | VP & General Counse ... | Buy | M | 0.89 | 250,000 | 222,500 | 438,360 | 188.4 K to 438.4 K (+132.72 %) |
Apr 09 2008 | GNBT | GENEREX BIOTECHNOL ... | BERNSTEIN GERALD | VP, Medical Affairs | Option Exercise | M | 1.00 | 50,000 | 50,000 | 0 | |
Apr 09 2008 | GNBT | GENEREX BIOTECHNOL ... | BERNSTEIN GERALD | VP, Medical Affairs | Buy | M | 1.00 | 50,000 | 50,000 | 53,469 | 3.5 K to 53.5 K (+1,441.34 %) |
Mar 12 2008 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Buy | P | 1.06 | 2,700 | 2,862 | 102,700 | 100 K to 102.7 K (+2.70 %) |
Mar 11 2008 | GNBT | GENEREX BIOTECHNOL ... | BERNSTEIN GERALD | V.P., Medical Affai ... | Option Exercise | A | 0.94 | 50,000 | 47,000 | 50,000 | |
Feb 28 2008 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Option Exercise | M | 1.00 | 70,000 | 70,000 | 275,714 | |
Feb 28 2008 | GNBT | GENEREX BIOTECHNOL ... | BARRATT JOHN P | Director | Buy | M | 1.00 | 70,000 | 70,000 | 495,714 | 425.7 K to 495.7 K (+16.44 %) |
Oct 25 2007 | GNBT | GENEREX BIOTECHNOL ... | BERNSTEIN GERALD | Director | Option Exercise | A | 1.71 | 50,000 | 85,500 | 50,000 | |
Aug 21 2007 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | Exec. VP & General ... | Grant | A | 0.00 | 175,000 | 0 | 188,360 | 13.4 K to 188.4 K (+1,309.88 %) |
Aug 30 2007 | GNBT | GENEREX BIOTECHNOL ... | Masterson Nola E | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Aug 21 2007 | GNBT | GENEREX BIOTECHNOL ... | PERRI ROSE C | COO, CFO, Sec., Tre ... | Grant | A | 0.00 | 175,000 | 0 | 379,726 | 204.7 K to 379.7 K (+85.48 %) |
Aug 21 2007 | GNBT | GENEREX BIOTECHNOL ... | GLUSKIN ANNA E | President & CEO | Grant | A | 0.00 | 200,000 | 0 | 216,127 | 16.1 K to 216.1 K (+1,240.16 %) |